Clin2
NCT06027554Possibly a fitRecruiting

MitoQ for frailty, walking, memory, and blood flow in older adults

FrailtyMild Cognitive ImpairmentAging

Part of Mental health clinical trials.

This trial tests whether a supplement called MitoQ can improve blood vessel health, walking speed, and thinking skills in older adults who are frail or have mild memory problems. It aims to see if MitoQ helps maintain independence and quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
65 years to 80 years
Study type
Interventional

Who can take part

  • You are between 65 and 80 years old
  • You walk slowly (less than 0.4 meters per second on a 4-meter walk) or have mild memory or thinking problems
  • You are not taking any medications for blood pressure, blood flow, or metabolism (like diabetes or cholesterol drugs)
  • You have not had a recent infection, vaccination, or hospitalization in the past few weeks to months
  • You do not have a bleeding disorder, are not on blood thinners, and have not had a recent fall
  • You are not taking immune-altering medicines (like high-dose steroids) or have a severe autoimmune disease

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07406243Not yet recruiting
Antioxidant therapy for brain artery health in older women

This trial tests whether an antioxidant pill can improve brain artery health in postmenopausal women. If you are at least 60, have not taken hormone therapy for 6 months, and are generally healthy, this study might be a good fit.

Fort Collins, Colorado
NCT07772336Not yet recruiting
Coenzyme Q10 for building resilience in older adults

This trial tests whether a daily supplement called Coenzyme Q10 (CoQ10) can help older adults become more resilient, meaning they can recover better from stress or illness. If you are 65 or older and have some signs of reduced physical function, this study might be a good fit for you.

NCT06208527Recruiting· Phase 2
Nicotinamide Riboside for Frailty in Older Adults

This trial tests whether a daily supplement called nicotinamide riboside can help older adults who feel weak or frail to get stronger and more energetic. It lasts for several months and involves simple tests like a walking test and memory checks.

Bergen, Vestland
NCT07144527Recruiting
NMN supplement for exercise in healthy older adults

This trial tests whether a supplement called nicotinamide mononucleotide (NMN) can help healthy adults aged 60 to 80 improve their exercise tolerance. You'll take the supplement and do supervised cycling sessions to see if it boosts your stamina.

Beverly Hills, California
NCT06470061Not yet recruiting· Phase 2
RQC to prevent Alzheimer's and eye changes

This study tests an oral medication called RQC to see if it can help prevent Alzheimer's disease and related eye changes. It is for adults aged 50–90 who do not have major memory problems or other serious health conditions.

Chicago, Illinois
NCT06191965Recruiting· Phase 2/Phase 3
MitoQ supplement for early psychosis

This study tests whether a supplement called MitoQ can help people with early-stage psychosis by improving how their cells produce energy. If you are younger and have been treated for psychosis for less than 5 years, this trial may be an option for you.

New Haven, Connecticut

Hear when a new Frailty trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.